Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
21 results
D3.101 - Etoricoxib Associated Fixed Drug Eruption: A Case Series from a Tertiary Allergy and Clinical Immunology Centre, United Arab Emirates
D3.93 - Clinical Efficacy of Tezepelumab in a Patient with Severe Refractory Mixed Asthma: A Case Report from Kazakhstan
D3.95 - Hidden in everyday cosmetics: Facial allergic contact dermatitis to fragrances
D3.97 - Allergic contact dermatitis confirmed by repeated open application test in a 68‑year‑old patient
D3.98 - An extended study for the multiple detection of IgE-mediated allergic reactions using microarray technology
D3.104 - Molecular Co-Sensitization Mapping Using a 192-Line Multiplex IgE Platform
D3.105 - Analysis of post-vaccination immunity in children with dermatology diseases receiving biologic and immunosuppressive therapy
D3.107 - Comparison of Cupressaceae sensitization allergens in a large Spanish cohort
D3.103 - Comprehensive Allergen Characterization for Standardized Basophil Activation Testing
D3.370 - Three cases of erdosteine-induced delayed drug hypersensitivity
D3.373 - Non-immediate Hypersensitivity Reactions To Both Penicillin and Aminopenicillin and Diagnostic approach – A Real Life Retrospective Study
D3.372 - Rapid Intramuscular Penicillin Desensitization: A Promising Future
D3.374 - Recall urticaria to dalteparin sodium in a patient with previous systemic reaction to nadroparin calcium
D3.375 - Delayed-Type Drug Reactions in Pediatric Patients: Clinical Features and Management
D3.376 - Drug Allergy Related to Chemotherapy and Premedication: Anaphylaxis Induced by Carboplatin and Methylprednisolone
D3.378 - Drug hypersensitivity in children in a frontline setting: interim results of a pilot epidemiological project
D3.380 - The Most Serious Threat in Perioperative Hypersensitivity Reactions (PHRs): Neuromuscular Blocking Agent (NMBA) Hypersensitivity and Cisatracurium as a Safe Haven in the Setting of Cross-Reactivity
D3.381 - The paradox of treatment: H1-antihistamines-induced urticaria in a patient with chronic spontaneous urticaria
D3.382 - Safety and outcomes of penicillin desensitization during pregnancy: experience from a tertiary referral center
D3.383 - Delayed T-cell–mediated hypersensitivity to dimethyl fumarate: clinical presentation and diagnostic considerations
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download